Concepedia

Marco Stellato

MS

Statistics

Publications

17

Citations

512

H-Index

13

Active since

2018

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

Università Campus Bio-Medico

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Istituto Oncologico Veneto

Marco Stellato is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in oncology, medicine, and renal cell carcinoma.

Publications per year

2018–2024

17

Publications

17

Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO

Emanuela Dell’Aquila, Chiara Cremolini, Tea Zeppola et al. · Annals of Oncology · 2018 · 134 citations · Full text

, , +17

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)

Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna et al. · Therapeutic Advances in Medical Oncology · 2021 · 93 citations · Full text

, , +17

Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study

Aldo Pezzuto, Marco Stellato, Giovanna Catania et al. · Journal of Breath Research · 2018 · 36 citations

, , +17

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib

Bruno Vincenzi, Margherita Nannini, Giuseppe Badalamenti et al. · Therapeutic Advances in Medical Oncology · 2018 · 33 citations · Full text

, , +13

Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)

Marco Stellato, Daniele Santini, Elena Verzoni et al. · Frontiers in Oncology · 2021 · 29 citations · Full text

, , +17

1–5 of 17